Amgen, Inc. (AMGN)
351.02
-4.58
(-1.29%)
USD |
NASDAQ |
Apr 10, 16:00
351.45
+0.43
(+0.12%)
After-Hours: 20:00
Amgen Free Cash Flow : 8.10B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 1.969B |
| Gilead Sciences, Inc. | 9.456B |
| Johnson & Johnson | 19.70B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Moderna, Inc. | -2.075B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.603B |
| Cash from Investing (Quarterly) | -693.00M |
| Cash from Financing (Quarterly) | -1.226B |
| Free Cash Flow Per Share (Quarterly) | 1.770 |
| Free Cash Flow to Equity (Quarterly) | 113.00M |
| Free Cash Flow to Firm (Quarterly) | 1.536B |
| Free Cash Flow Yield | 4.26% |